lisuride
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Dopergin, others |
| Other names | Lysuride; Mesorgydin; Methylergol carbamide; 1,1-Diethyl-3-(6-methyl-9,10-didehydroergolin-8α-yl)urea |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Drug class | Serotonin receptor agonist; Dopamine receptor agonist |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 10–20% |
| Protein binding | 60–70% |
| Metabolism | Hepatic |
| Metabolites | More than 15 known |
| Elimination half-life | 2 hours |
| Excretion | Renal and biliary in equal amounts |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C20H26N4O |
| Molar mass | 338.455 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Főnév
lisuride (tsz. lisurides)